Continuing Appropriations Act, 2021 and Other Extensions Act [HB-8337]
[Healthcare ]
[Transportation and Motor Vehicles ]
[Agriculture ]
[Veterans ]
[Immigration ]
[Budget and Spending ]
[Small Business ]
[Cybersecurity ]
[Disaster Relief ]
[Economic Development ]
[Food ]
[Public Health ]
[Medicare and Medicaid ]
[Children and Youth ]
[Criminal Justice ]
[Funding ]
[Grants ]
[Human Services ]
[Law Enforcement ]
[Libraries ]
[Military ]
[National Security ]
[Poverty ]
[Public Safety ]
[Energy ]
[Telecommunications ]
[Labor, Jobs, Employment ]
[Construction ]
[Housing ]
[Senior Citizens ]
[Science ]
[Technology and Innovation ]
[Animals ]
[Water ]
[Arts and Culture ]
[Education ]
[Family-Related Legislation ]
[Finance ]
[Infrastructure ]
[International ]
[Real Estate ]
[Taxes ]
[Trade ]
[Unemployment ]
[Workers' Compensation ]
[Crime ]
Provides continuing FY2021 appropriations to federal agencies and extends expiring programs that address health care, surface transportation, agriculture, veterans benefits, and other issues. DIVISION A--CONTINUING APPROPRIATIONS ACT, 2021 Continuing Appropriations Act, 2021 This division provides continuing FY2021 appropriations to federal agencies through December 11, 2020. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2021 appropriations bills have not been enacted when FY2021
(continued...)
HB-8337: Continuing Appropriations Act, 2021 and Other Extensions Act
Sponsored by: Rep. Nita Lowey
Became Public Law No: 116-159. (txt | Pdf) on 10/01/2020
SR-706: A resolution expressing support for the designation of September 2020 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.
Sponsored by: Sen. Cory Booker
Submitted In The Senate, Considered, And Agreed To Without Amendment And With A Preamble By Unanimous Consent. on 09/17/2020
You have voted SR-706: A resolution expressing support for the designation of September 2020 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease..
ETHIC Act Ensuring Transparent Honest Information on COVID–19 Act [HB-8205]
[Healthcare ]
[Public Health ]
[Funding ]
[Grants ]
[Technology and Innovation ]
[Data Privacy ]
[Science ]
[Native American Affairs ]
[Race and Civil Rights ]
Retroactively requires states and other jurisdictions to report specified COVID-19 (i.e., coronavirus disease 2019) data to the Centers for Disease Control and Prevention (CDC) as a condition of receiving certain COVID-19 funding. It also directs the CDC and others to take additional actions to address public health data systems, public health infrastructure, and health disparities. Specifically, the bill directs the CDC to improve its data systems, develop relevant data and technology systems, and expand its public health infrastructure. The CDC
(continued...)
HB-8205: ETHIC Act Ensuring Transparent Honest Information on COVID–19 Act
Sponsored by: Rep. Kathy Castor
Referred To The Subcommittee For Indigenous Peoples Of The United States. on 09/16/2020
COVID Community Care Act [HB-8192]
[Budget and Spending ]
[Healthcare ]
[Public Health ]
[Funding ]
[Grants ]
[Disaster Relief ]
Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes.
HB-8192: COVID Community Care Act
Sponsored by: Rep. Raul Grijalva
Introduced In House on 09/08/2020
Biosimilar Insulin Access Act of 2020 [HB-8190]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes.
HB-8190: Biosimilar Insulin Access Act of 2020
Sponsored by: Rep. Glenn Grothman
Sponsor Introductory Remarks On Measure. (cr H4487) on 09/16/2020
RAISE Act Renal Anemia Innovation Support and Expansion Act [HB-8177]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Public Health ]
Allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.
HB-8177: RAISE Act Renal Anemia Innovation Support and Expansion Act
Sponsored by: Rep. Tom O'Halleran
Introduced In House on 09/04/2020
Science in Blood Donation Act of 2020 [HB-8168]
[Healthcare ]
[Public Health ]
[Science ]
[Human Rights ]
[Food ]
To require the guidance of the Food and Drug Administration on reducing the risk of human immunodeficiency virus (HIV), hepatitis A, and hepatitis B transmission by blood and blood products (including the donor history questionnaire) to be based on an individual risk assessment of sexual behaviors upon which all donors are evaluated equally, without regard to sexual orientation or gender identity, and for other purposes.
HB-8168: Science in Blood Donation Act of 2020
Sponsored by: Rep. Mike Quigley
Introduced In House on 09/04/2020
Improving COVID–19 Data Transparency Act [HB-8073]
[Healthcare ]
[Public Health ]
[Technology and Innovation ]
[Data Privacy ]
[Science ]
Requires the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS) to take certain actions with respect to reporting and modeling COVID-19 (i.e., coronavirus disease 2019) data. It also requires health information technology, as a condition of certification by HHS, to automatically generate and transmit reports of possible reportable conditions from electronic health records to public health agencies. The CDC must standardize the reporting of COVID-19 data by governmental health departments, including
(continued...)
HB-8073: Improving COVID–19 Data Transparency Act
Sponsored by: Rep. Gerald Connolly
Introduced In House on 08/21/2020
Maternal Health Pandemic Response Act of 2020 [HB-8027]
[Healthcare ]
[Public Health ]
[Labor, Jobs, Employment ]
[Family-Related Legislation ]
[Data Privacy ]
[Science ]
[Pharmaceuticals ]
[Human Services ]
[Native American Affairs ]
[Children and Youth ]
[Medicare and Medicaid ]
Addresses maternal health during the COVID-19 (i.e., coronavirus disease 2019) emergency by supporting data collection, development of COVID-19 therapeutics and workplace protections, and other activities. Specifically, the Department of Health and Human Services must issue guidance for states and local health departments on collecting data on pregnancy and postpartum status in conjunction with COVID-19 tests. In addition, the bill provides funds for the Centers for Disease Control and Prevention (CDC) to expand particular maternal health surveillance
(continued...)
HB-8027: Maternal Health Pandemic Response Act of 2020
Sponsored by: Rep. Eleanor Norton
Referred To The Subcommittee For Indigenous Peoples Of The United States. on 09/04/2020
WIC Waiver Extension Act of 2020 [HB-8024]
[Agriculture ]
[Healthcare ]
[Public Health ]
[Food ]
[Children and Youth ]
[Disaster Relief ]
[Funding ]
[Grants ]
[Human Services ]
Extends authority through September 30, 2021, for the Department of Agriculture (USDA) to grant certain waivers to participants under the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, USDA may grant waivers allowing participants under WIC to get certified or recertified without being physically present at a WIC clinic; defer anthropometric and bloodwork requirements necessary to determine nutritional risk; and grant waivers
(continued...)
HB-8024: WIC Waiver Extension Act of 2020
Sponsored by: Rep. Jaime Herrera Beutler
Introduced In House on 08/11/2020
Safely Back to School and Back to Work Act [S.4322]
[Education ]
[Labor, Jobs, Employment ]
[Public Health ]
[Economic Development ]
A bill to help Americans safely get back to school and back to work, and for other purposes.
S.4322: Safely Back to School and Back to Work Act
Sponsored by: Sen. Lamar Alexander
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/27/2020
Plasma Donation Awareness Act of 2020 [HB-7783]
[Healthcare ]
[Public Health ]
To amend the CARES Act to expand a national awareness and outreach campaign to address the importance and safety of plasma donation, and for other purposes.
HB-7783: Plasma Donation Awareness Act of 2020
Sponsored by: Rep. Robin Kelly
Introduced In House on 07/24/2020
COVID–19 Data Transparency Act [HB-7674]
[Public Health ]
[Healthcare ]
[Data Privacy ]
[Technology and Innovation ]
To require the Director of the Centers for Disease Control and Prevention to create a standardized method for State, Tribal, and local health departments to report to the Centers with respect to COVID-19, and for other purposes.
HB-7674: COVID–19 Data Transparency Act
Sponsored by: Rep. Raul Grijalva
Introduced In House on 07/20/2020
Affordable Coronavirus Testing Act [S.4198]
[Healthcare ]
[Medicare and Medicaid ]
[Insurance ]
[Public Health ]
[Veterans ]
[Children and Youth ]
[Funding ]
[Grants ]
[Pharmaceuticals ]
[Public Safety ]
[Disaster Relief ]
Requires health insurance plans to cover through 2021 without cost sharing COVID-19 (i.e., coronavirus disease 2019) serology testing, which looks for the presence of antibodies made in response to an infection. This coverage requirement also applies to federal health care programs including Medicare, Medicaid, the Children's Health Insurance Program, veterans and military personnel health benefits, and federal employee health benefits. Additionally, the bill requires the Department of Health and Human Services to reimburse, through the Public Health
(continued...)
S.4198: Affordable Coronavirus Testing Act
Sponsored by: Sen. Martha McSally
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/02/2020
Plasma Donation Awareness Act [S.4179]
[Healthcare ]
[Public Health ]
A bill to update the blood donation public awareness campaign of the Department of Health and Human Services to include public awareness on plasma donation.
S.4179: Plasma Donation Awareness Act
Sponsored by: Sen. Amy Klobuchar
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/02/2020
Work Safe Act [S.3966]
[Taxes ]
[Healthcare ]
[Labor, Jobs, Employment ]
[Small Business ]
[Public Health ]
[Economic Development ]
[Funding ]
[Grants ]
Allows employers a tax credit for providing testing for COVID-19 (i.e., coronavirus disease 2019). The bill also requires the Centers for Disease Control and Prevention to disclose the COVID-19 weekly positive case rate for each state and the United States for the most recent calendar week.
S.3966: Work Safe Act
Sponsored by: Sen. Ted Cruz
Read Twice And Referred To The Committee On Finance. on 06/16/2020
PFAS Exposure Assessment and Documentation Act [S.3911]
[Defense ]
[Environmental ]
[Public Health ]
[Military ]
[Water ]
A bill to require the Secretary of Defense to establish a task force to address the effects of the release of perfluoroalkyl substances and polyfluoroalkyl substances from activities of the Department of Defense, to include exposure to such substances in periodic health assessments of members of the Armed Forces, and for other purposes.
S.3911: PFAS Exposure Assessment and Documentation Act
Sponsored by: Sen. Margaret Hassan
Read Twice And Referred To The Committee On Armed Services. on 06/08/2020
COVID–19 Emergency Manufacturing Act of 2020 [HB-7113]
[Healthcare ]
[Public Health ]
[Manufacturing ]
[Economic Development ]
[Funding ]
To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
HB-7113: COVID–19 Emergency Manufacturing Act of 2020
Sponsored by: Rep. Janice Schakowsky
Introduced In House on 06/04/2020
COVID–19 Emergency Manufacturing Act of 2020 [S.3847]
[Healthcare ]
[Public Health ]
[Manufacturing ]
[Economic Development ]
A bill to amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
S.3847: COVID–19 Emergency Manufacturing Act of 2020
Sponsored by: Sen. Elizabeth Warren
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 06/01/2020